| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis
|
Nishijima, Tomohiro F.
|
|
2016
|
156 |
2 |
p. 227-236
|
artikel
|
| 2 |
Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany
|
Vetter, Lisa
|
|
2016
|
156 |
2 |
p. 289-299
|
artikel
|
| 3 |
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
|
Limentani, Steven A.
|
|
2016
|
156 |
2 |
p. 319-330
|
artikel
|
| 4 |
A novel gene expression signature for bone metastasis in breast carcinomas
|
Savci-Heijink, C. Dilara
|
|
2016
|
156 |
2 |
p. 249-259
|
artikel
|
| 5 |
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
|
Curigliano, Giuseppe
|
|
2016
|
156 |
2 |
p. 301-310
|
artikel
|
| 6 |
Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27
|
Chapman, Judith-Anne W.
|
|
2016
|
156 |
2 |
p. 343-349
|
artikel
|
| 7 |
Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
|
Rangel, Maria Cristina
|
|
2016
|
156 |
2 |
p. 211-226
|
artikel
|
| 8 |
Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
|
Kwan, Marilyn L.
|
|
2016
|
156 |
2 |
p. 379-389
|
artikel
|
| 9 |
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
|
Kida, Kumiko
|
|
2016
|
156 |
2 |
p. 261-269
|
artikel
|
| 10 |
Equivalence of MammaPrint array types in clinical trials and diagnostics
|
Beumer, Inès
|
|
2016
|
156 |
2 |
p. 279-287
|
artikel
|
| 11 |
Erratum to: Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
|
Bartella, V.
|
|
2016
|
156 |
2 |
p. 409
|
artikel
|
| 12 |
Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue
|
Vilasco, Myriam
|
|
2016
|
156 |
2 |
p. 401-402
|
artikel
|
| 13 |
Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
|
Tang, Jun
|
|
2016
|
156 |
2 |
p. 403-404
|
artikel
|
| 14 |
Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
|
Wander, Seth A.
|
|
2016
|
156 |
2 |
p. 405-406
|
artikel
|
| 15 |
Erratum to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition
|
Yin, Chonggao
|
|
2016
|
156 |
2 |
p. 407-408
|
artikel
|
| 16 |
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer
|
Matsumoto, Hirofumi
|
|
2016
|
156 |
2 |
p. 237-247
|
artikel
|
| 17 |
Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer
|
Check, Devon K.
|
|
2016
|
156 |
2 |
p. 351-359
|
artikel
|
| 18 |
Is ultrasound-guided fine-needle aspiration cytology of adequate value in detecting breast cancer patients with three or more positive axillary lymph nodes?
|
Kramer, G. M.
|
|
2016
|
156 |
2 |
p. 271-278
|
artikel
|
| 19 |
Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients
|
Hénin, Emilie
|
|
2016
|
156 |
2 |
p. 331-341
|
artikel
|
| 20 |
Should the hyperechogenic halo around malignant breast lesions be included in the measurement of tumor size?
|
Joekel, Judith
|
|
2016
|
156 |
2 |
p. 311-317
|
artikel
|
| 21 |
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
|
Engels, Charla C.
|
|
2016
|
156 |
2 |
p. 361-370
|
artikel
|
| 22 |
The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients
|
Huzarski, T.
|
|
2016
|
156 |
2 |
p. 371-378
|
artikel
|
| 23 |
Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period
|
Bosma, S. C. J.
|
|
2016
|
156 |
2 |
p. 391-400
|
artikel
|
Tijdschrift beschrijving